October 20, 2021
CORRECTION – Neuronetics Announces Preliminary Revenue for Third Quarter 2021
MALVERN, Pa., Oct. 19, 2021 (GLOBE NEWSWIRE) — In a release issued under the same headline on Tuesday, October 12th…
Pharmaceuticals, Biotechnology and Life Sciences
MALVERN, Pa., Oct. 19, 2021 (GLOBE NEWSWIRE) — In a release issued under the same headline on Tuesday, October 12th…
PHILADELPHIA, Oct. 19, 2021 (GLOBE NEWSWIRE) — Context Therapeutics Inc. (the “Company”) (Nasdaq: CNTX), a women’s oncology company developing advanced…
Telix IPAX-1 Overall Survival Overall survival (to date) indicates a median 15.97 months OS, with three patients exhibiting stable disease…
LOS ANGELES, Oct. 19, 2021 (GLOBE NEWSWIRE) — Aadi Bioscience, Inc. (“Aadi”), a privately-held clinical-stage biopharmaceutical company focusing on precision…
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH…
NEW YORK, Oct. 19, 2021 (GLOBE NEWSWIRE) — Cellectis S.A. (NASDAQ: CLLS – EURONEXT GROWTH: ALCLS) (the “Company”), a gene-editing…
DEVON, Pa., Oct. 19, 2021 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid…
SOUTH SAN FRANCISCO, Oct. 19, 2021 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic biotechnology company developing transformational treatments for…
David Millan, PhD, VP of Chemistry, to present overview of company’s proprietary protein degrader platform and its clinical stage asset,…
LEXINGTON, Mass., Oct. 19, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing…